Advocacy intelligence hub — real-time data for patient organizations
Universidad Europea de Madrid — NA
Universidad Autonoma de Madrid — NA
Brazilian Clinical Research Institute — NA
University of Florida — NA
Protara Therapeutics — PHASE3
Gali Perel — NA
University of Wisconsin, Madison — PHASE1
State University of Londrina — NA
University of Sao Paulo — NA
University of Oklahoma — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Global Clinical Leader
Daiichi Sankyo
Giuseppe Procopio, MD, R. Ph
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
📍 RAHWAY, NJ
Chief Scientific Operations Officer
Protara Therapeutics
Yoshitaka Shimizu
Kissei Pharmaceutical Co., Ltd.
Alice P Chen, M.D.
National Cancer Institute (NCI)
Samuel Funt, MD, M.D
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY